References and Notes
1 For a review, see: Matsuda I.
In Modern Rhodium-Catalyzed Organic Reactions
Evans PA.
Wiley-VCH;
Weinheim:
2005.
Chap.
6.
p.111-128
2a
Zhao D.
Oisaki K.
Kanai M.
Shibasaki M.
Tetrahedron
Lett.
2006,
47:
1403
2b
Zhao D.
Oisaki K.
Kanai M.
Shibasaki M.
J. Am. Chem. Soc.
2006,
128:
14440
3a
Deschamp J.
Chuzel O.
Hannedouche J.
Riant O.
Angew.
Chem. Int. Ed.
2006,
45:
1292
3b
Chuzel O.
Deschamp J.
Chausteur C.
Riant O.
Org. Lett.
2006,
8:
5943
4a
Nishiyama H.
Shiomi T.
Tsuchiya Y.
Matsuda I.
J.
Am. Chem. Soc.
2005,
127:
6972
4b
Ito J.-i.
Shiomi T.
Nishiyama H.
Adv.
Synth. Catal.
2006,
348:
1235
4c
Shiomi T.
Ito J.-i.
Yamamoto Y.
Nishiyama H.
Eur. J. Org. Chem.
2006,
5594
4d
Shiomi T.
Nishiyama H.
Org. Lett.
2007,
9:
1651
4e
Nishiyama H.
Ito J.-i.
Chem. Rec.
2007,
7:
159
5a
Lumby RJR.
Joensuu PM.
Lam HW.
Org.
Lett.
2007,
9:
4367
5b
Lam HW.
Joensuu PM.
Org. Lett.
2005,
7:
4225
6a
Fukuzawa S.-i.
Oki H.
Hosaka M.
Sugasawa J.
Kikuchi S.
Org. Lett.
2007,
9:
5557
6b
Fukuzawa S.-i.
Oki H.
Org. Lett.
2008,
10:
1747
7 The use of other silanes such as dimethylphenylsilane, diethylmethylsilane,
and triethoxysilane resulted in poor yields and selectivities under
the same conditions.
8 Additives such as the triethylamine
and tricyclohexyl phosphine did not affect the stereoselectivity.
9
Preparation of
(
S
,
Rp
)-5-(Diphenylphosphino)-1-{1-[2-(diphenylphosphino)ferrocenyl]ethyl}-1
H
-1,2,3-triazole (CF2)
A
100 mL round-bottom flask containing a magnetic stirring bar was
charged with 1-(1-azidoethyl)-2-bromoferrocene (400 mg, 1.20 mmol),
trimethylsilylacetylene (180 µL, 1.32 mmol), t-BuOH (3.0 mL), and H2O (3.0
mL). Sodium ascorbate (257 mg, 1.32 mmol) was added to the flask followed
by CuSO4˙7H2O (162 mg, 0.65 mmol),
and the resulting mixture was magnetically stirred for 24 h. The mixture
was then extracted with CH2Cl2 (10 × 3
mL). The combined extracts were washed(brine), dried (MgSO4),
and the solvent was removed on a rotary evaporator to leave a yellow
residue. The residue was treated overnight with a THF (5.0 mL) solution
of TBAF (1.5 mmol) in THF at 50 ˚C. THF was removed
by using a rotary evaporator and diluted with CH2Cl2 (20
mL) The solution was washed with H2O, dried (MgSO4),
and the solvent was removed using a rotary evaporator. The residue
was subjected to column chromatography on SiO2 (hexane-EtOAc = 2:1
as eluent) to give the pure (S,Rp)-1-[1-(2-bromoferrocenyl)ethyl]-1H-1,2,3-triazole. Yellow solid; yield
140 mg, 0.40 mmol, 33%; mp 120-121 ˚C; [α]D
²5 +81
(c 0.36, CHCl3). ¹H
NMR (300 MHz, CDCl3): δ = 2.04 (d,
3 H, J = 6.4
Hz), 4.26 (s, 5 H), 4.42 (s, 1 H), 4.53 (s, 1 H), 5.88 (q, 1 H, J = 6.9 Hz),
7.30 (s, 1 H), 7.56 (s, 1 H). ¹³C NMR
(75 MHz, CDCl3): δ = 21.0, 54.9, 64.9,
66.9, 71.1, 71.5, 79.1, 84.6, 121.7, 132.9.
In a 20 mL
Schlenk tube containing a magnetic stirring bar were charged the
triazole bromoferrocene prepared above (100 mg, 0.28 mmol) and dry
THF (3.0 mL) under a slight pressure of nitrogen. The flask was
cooled at -78 ˚C, and a hexane solution
of n-BuLi (0.44 mL, 0.70 mmol, 1.6 M)
was then added using a syringe through the septum with mag-netic
stirring. After 10 min, Ph2PCl (130 µL, 0.70
mmol) was injected into the mixture at -78 ˚C
and stirred for 1 h. When the addition was completed, the mixture
was allowed to warm to r.t. and then stirred for an additional 2
h. The reaction was quenched with sat. NH4Cl, and the
solution was then extracted with Et2O (3 × 20
mL). The combined extracts were washed(brine), dried (Na2SO4),
filtered, and the solvent was removed on a rotary evaporator to
leave a yellow solid. The crude CF2 was
purified by recrystal-lization from hexane-CH2Cl2.
Yellow solid; yield, 130 mg, 0.20 mmol, 73%; mp 167-168 ˚C; [α]D
²5 +95
(c 0.34, CHCl3). ¹H
NMR (300 MHz, CDCl3): δ = 1.61 (d,
3 H, J = 6.8
Hz), 3.81 (s, 1 H), 4.10 (s, 5 H), 4.45 (t, 1 H, J = 2.6 Hz),
4.90 (s, 1 H), 6.30 (m, 1 H), 6.60-7.60 (m, 21 H). ¹³C NMR
(75 MHz, CDCl3): δ = 21.6, 53.9 (dd, J = 9.2, 11.7), 69.8,
70.2, 70.8 (d, J = 3.7
Hz), 71.8 (d, J = 4.9
Hz), 75.3 (d, J = 10.2
Hz), 92.4 (d, J = 26.0
Hz), 127.0, 127.7 (d, J = 5.5 Hz),
127.9 (d, J = 8.1
Hz), 128.1 (d, J = 6.8
Hz), 128.3 (d, J = 7.2
Hz), 128.7, 128.8, 129.2, 129.8, 130.9 (d, J = 16.9 Hz),
132.4 (d, J = 18.6
Hz), 133.1 (d, J = 7.2
Hz), 133.3, 133.4, 133.5 (d, J = 7.9
Hz), 134.0, 134.1 (d, J = 21.5
Hz), 135.4 (d, J = 21.1
Hz), 137.1 (d, J = 8.5
Hz), 138.6, 139.1 (d, J = 9.6
Hz). ³¹P NMR (121 MHz, CDCl3): δ = -40.4
(d, J = 37.0
Hz), -24.5 (d, J = 37.0
Hz). HRMS: m/z calcd for C38H33FeN3P2 [M + H+]:
650.1577; found: 650.1573. The crystallographic data can be obtained
free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
CCDC-717051.
Compound CF4 was
similarly prepared by replacing Ph2Cl with Cy2PCl.
Yellow solid; yield, 58%; mp 100-102 ˚C; [α]D
²5 +197
(c 0.24, CHCl3). ¹H
NMR (300 MHz, CDCl3):
δ = 0.90-2.10
(m, 47 H) including 2.04 (d, J = 7.0
Hz), 4.18 (s, 1 H), 4.26 (s, 5 H), 4.38 (s, 1 H), 6.12 (m, 1 H),
7.66 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 23.2,
53.9 (dd, J = 9.6, 12.0
Hz), 26.0-36.0 (several cyclohexyl signals), 69.0, 69.3, 69.6,
71.3 (d, J = 4.3
Hz), 79.3 (d, J = 24.6
Hz), 93.8 (d, J = 25.8
Hz), 131.7 (d, J = 24.3
Hz), 137.8 (d, J = 4.7). ³¹P NMR
(121 MHz, CDCl3): δ = -33.0
(s), -19.3 (s). HRMS: m/z calcd
for C38H57FeN3P2 [M + H+]:
674.3455; found: 674.3456.
Compound CF3 was prepared by a similar preparative method
for CF1 by replacing Ph2PCl
with Cy2PCl according to a previous study.
[6a]
Yellow solid; mp 100-101 ˚C; [α]D
²5 +97
(c 0.31, CHCl3). ¹H
NMR (300 MHz, CDCl3): δ = 0.90-2.30
(m, 47 H) including 2.04 (d, J = 6.9
Hz), 4.19 (s, 1 H), 4.29 (s, 5 H), 4.33 (s, 1 H), 6.17 (m, 1 H),
7.30-7.40 (m, 5 H). ¹³C NMR
(75 MHz, CDCl3): δ = 23.6 (dd, J = 3.2, 7.7 Hz),
26.0-36.0 (several cyclohexyl signals), 54.2, 68.5, 69.7,
71.2, 71.3, 78.4 (d, J = 25.3
Hz), 95.3 (d, J = 24.8), 127.9,
128.1, 128.4 (d, J = 30.
0 Hz), 129.3, 133.2, 151.6. ³¹P NMR
(121 MHz, CDCl3): δ = -28.7
(s), -18.0 (s). HRMS: m/z calcd
for C44H61FeN3P2 [M + H+]:
750.3768; found: 750.3767.
10
General Procedure
for Cu/CF3-Mediated Reductive Aldol Reaction of Ketones
1 with Methyl Acrylate (2)
Under
nitrogen, a 20 mL well-dried Schlenk tube equipped with a magnetic
stirrer was charged with CuF(PPh3)3˙2MeOH
(9.0 mg, 0.01 mmol), CF3 (7.5 mg, 0.01
mmol), and toluene (4.8 mL). The catalyst solution was stirred for
30 min at r.t., and phenylsilane (180 µL, 1.40 mmol) was
then added at the same temperature. After cooling the solution at -50 ˚C,
methyl acrylate (2, 110 µL, 1.20
mmol) and acetophenone (120 mg, 1.00 mmol) were simultaneously added
to the solution. The mixture was stirred for 1 h at -50 ˚C,
and then quenched by adding an aq NH4F soln (5 mL). The
aqueous layer was extracted by three portions of Et2O
(5 mL). The combined organic layers were then washed with brine
(20 mL), dried over MgSO4, filtered and concentrated
by an evaporator. The residue was subjected to short SiO2 column
chromatography (hexane-EtOAc as the eluent) to give a diastereomeric
mixture of the aldol adduct. The dr (erythro/threo) and ee values were determined
by GC (CP CHIRASIL DEX CB 25 m) with reference to the literature.
erythro
-Methyl
3-Hydroxy-2-methyl-3-phenylbutanoate (3a)
¹H
NMR (300 MHz, CDCl3): δ = 1.32 (d,
3 H, J = 7.0
Hz), 1.46 (s, 3 H), 3.03 (q, 1 H, J = 7.0
Hz), 3.45 (s, 3 H), 4.02 (s, 1 H), 7.20-7.40 (m, 5 H). ¹³C
NMR (75 MHz, CDCl3): δ = 12.45, 26.6,
48.5, 51.6, 74.6, 124.6, 126.7, 128.1, 147.5, 177.1. GC Chirasil-Dex
CB, 25 mm; isotherm 120 ˚C, t
R(major) = 18.5
min, t
R(minor) = 19.4
min. Other aldol products are fully characterized by spectroscopic
analysis and the dr and ee values of products were determined by
GC.